| Name | Title | Contact Details |
|---|
Every day` 119`000 compassionate caregivers serve patients and communities through Providence St. Joseph Health` a national` Catholic` not-for-profit health system` driven by a belief that health is a human right. Rooted in the founding missions of the Sisters of Providence and the Sisters of St. Joseph of Orange` courageous women ahead of their time who brought health care and other social services to the American West when it was still a rugged` untamed frontier` we share a singular commitment to improve the health of all. From our earliest days` we’ve met new challenges by pioneering new solutions. Today` with 51 hospitals` 829 clinics and a comprehensive range of services` we strive to meet the needs of communities across Alaska` California` Montana` New Mexico` Oregon` Texas and Washington through a diverse family of Catholic` other faith-based and mission-driven secular organizations. Now` as we face a new frontier—a changing health care landscape—we draw upon their pioneering and compassionate spirit to plan for the next century of health for a better world` especially for the poor and vulnerable. If you need treatment` please visit www.providence.org to locate a health care provider.
At RACSB, we are committed to helping community members lead the best lives possible, whether they need a little lift or a lifetime of support.
Hospice El Paso, Inc. is a El Paso, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Union Printers Home is a Colorado Springs, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.